- homeostasis/metabolism phenotype / MGI
- abnormal physiological response to xenobiotic / MGI
- decreased cardiomyocyte apoptosis / MGI
- abnormal myocardium layer morphology / MGI
- abnormal T cell activation / MGI
- decreased T cell proliferation / MGI
- decreased T cell apoptosis / MGI
- reduced long term potentiation / MGI
- abnormal excitatory postsynaptic potential / MGI
- decreased paired-pulse facilitation / MGI
- decreased post-tetanic potentiation / MGI
- abnormal neurotransmitter secretion / MGI
B6.129-Mapk9tm1Mka/Kctt
Status | Available to order |
EMMA ID | EM:01773 |
Citation information | RRID:IMSR_EM:01773 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | B6.129-Mapk9tm1Mka/Kctt |
Alternative name | Jnk2-C57Bl6 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Mapk9tm1Mka |
Gene/Transgene symbol | Mapk9 |
Information from provider
Provider | Ingrid Fossar-Larsen |
Provider affiliation | Department of Molecular Cancer Biology, Danish Cancer Society |
Genetic information | The Mapk9 (Jnk2) gene is disrupted by insertion of the lacZ cassette at the first exon. This mutation inactivates all known Mapk9 splicing variants. |
Phenotypic information | No major defects. Defects in T-cell apoptosis and proliferation. Mice are sensitive to arthritis. |
References |
|
Information from EMMA
Archiving centre | Karolinska Institutet, Stockholm, Sweden |
Disease and phenotype information
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- abnormal liver physiology / MGI
- thick epidermis / MGI
- epidermal hyperplasia / MGI
- reduced long term potentiation / MGI
- abnormal T cell activation / MGI
- abnormal keratinocyte morphology / MGI
- abnormal excitatory postsynaptic potential / MGI
- decreased paired-pulse facilitation / MGI
- decreased post-tetanic potentiation / MGI
- decreased cardiomyocyte apoptosis / MGI
- decreased T cell proliferation / MGI
- decreased susceptibility to injury / MGI
- abnormal myocardium layer morphology / MGI
- homeostasis/metabolism phenotype / MGI
- cardiovascular system phenotype / MGI
- abnormal neurotransmitter secretion / MGI
- abnormal enzyme/coenzyme activity / MGI
- decreased T cell apoptosis / MGI
- abnormal T-helper 1 cell differentiation / MGI
- abnormal physiological response to xenobiotic / MGI
- increased keratohyalin granule number / MGI
- decreased sensitivity to induced morbidity/mortality / MGI
Literature references
- c-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation.;Sabapathy K, Kallunki T, David J P, Graef I, Karin M, Wagner E F, ;2001;The Journal of experimental medicine;193;317-28; 11157052
- A central role for JNK in obesity and insulin resistance.;Hirosumi Jiro, Tuncman Gürol, Chang Lufen, Görgün Cem Z, Uysal K Teoman, Maeda Kazuhisa, Karin Michael, Hotamisligil Gökhan S, ;2002;Nature;420;333-6; 12447443
- JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development.;Sabapathy K, Hu Y, Kallunki T, Schreiber M, David J P, Jochum W, Wagner E F, Karin M, ;1999;Current biology : CB;9;116-25; 10021384
- Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis.;Han Zuoning, Chang Lufen, Yamanishi Yuji, Karin Michael, Firestein Gary S, ;2002;Arthritis and rheumatism;46;818-23; 11920420
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).